APhA Member News

Updates from FDA

A tube of nonprescription antibiotic ointment or bottle of antiseptic is a staple in most medicine cabinets, and for good reason. These products can prevent infection of small cuts, scrapes, or other skin injuries that don’t require medical intervention.

Mary Warner

Piperine, a major component of black pepper (Piper nigrum), is responsible for black pepper’s distinct flavor, is what makes you sneeze, and gives black pepper its reputation for having antioxidant and antiinflammatory properties.

Mickie Cathers

In May of 2023, FDA approved Brixadi (Braeburn Inc.), a new dosage form of the partial opioid agonist buprenorphine.

Lauren Howell, PharmD

Since May 2023, FDA has approved two respiratory syncytial virus (RSV) vaccines; the first time a vaccine for RSV has been approved for use in the United States.

Lauren Howell, PharmD

FDA approved fezolinetant (Veozah–Astellas Pharma US), a first-in-class neurokinin 3 (NK3) receptor antagonist, for the treatment of moderate to severe vasomotor symptoms (VMS) of menopause in May 2023.

Sonya Collins

The number of annual calls to poison control for pediatric melatonin overdoses increased by a whopping 530% from 2012 to 2021.

Sonya Collins

In 1991, Mark Beers, MD, and colleagues at University of California Los Angeles developed the Beers Criteria to identify potentially inappropriate medication (PIM) for nursing home residents. Since their initial release, the Beers Criteria has been updated six times and expanded the criteria to apply to all adults 65 years and older.

Daniel A. Hussar, PhD

Palforzia (peanut allergen powder-dnfp–Aimmune Therapeutics), which was FDA-approved in 2020, has been giving people with peanut allergies protection from severe reactions.

Clarissa Chan, PharmD